|
TMEM199 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.33066907387547E-16 |
| Normal-vs-Stage2 |
3.533299985925E-09 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
3.227000E-01 |
| Stage1-vs-Stage3 |
1.567210E-04 |
| Stage1-vs-Stage4 |
6.481900E-03 |
| Stage2-vs-Stage3 |
1.092190E-01 |
| Stage2-vs-Stage4 |
2.870800E-01 |
| Stage3-vs-Stage4 |
6.151400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.63458135915562E-12 |
| Normal-vs-Asian |
7.543200E-01 |
| Caucasian-vs-AfricanAmerican |
4.823400E-01 |
| Caucasian-vs-Asian |
2.446200E-01 |
| AfricanAmerican-vs-Asian |
2.065600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.46059830896661E-11 |
| Male-vs-Female |
1.08320000002937E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.83120000052384E-07 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
3.028300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.626390E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.936590E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.637000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.986000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.529000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.210400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.989800E-04 |
| Normal-vs-Grade 2 |
2.8421709430404E-14 |
| Normal-vs-Grade 3 |
<1E-12 |
| Normal-vs-Grade 4 |
1.62447832963153E-12 |
| Grade 1-vs-Grade 2 |
6.270400E-01 |
| Grade 1-vs-Grade 3 |
8.064300E-02 |
| Grade 1-vs-Grade 4 |
6.200200E-03 |
| Grade 2-vs-Grade 3 |
1.063460E-03 |
| Grade 2-vs-Grade 4 |
2.08150000002849E-06 |
| Grade 3-vs-Grade 4 |
3.632300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.63709062867201E-12 |
| Normal-vs-ccB subtype |
1.62447832963153E-12 |
| ccA subtype-vs-ccB subtype |
1.89199989009126E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
2.20829999952876E-07 |
| N0-vs-N1 |
6.459000E-01 |
|
|
